Cullen/Frost Bankers’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-137
| Closed | -$1.81K | – | 1476 |
|
|
2024
Q4 | $1.81K | Buy |
+137
| New | +$1.81K | ﹤0.01% | 1156 |
|
|
2022
Q4 | – | Sell |
-903
| Closed | -$12K | – | 1199 |
|
|
2022
Q3 | $12K | Buy |
+903
| New | +$12K | ﹤0.01% | 925 |
|
|
2022
Q1 | – | Sell |
-125
| Closed | -$2K | – | 1247 |
|
|
2021
Q4 | $2K | Hold |
125
| – | – | ﹤0.01% | 1084 |
|
|
2021
Q3 | $2K | Hold |
125
| – | – | ﹤0.01% | 1169 |
|
|
2021
Q2 | $2K | Hold |
125
| – | – | ﹤0.01% | 1165 |
|
|
2021
Q1 | $2K | Hold |
125
| – | – | ﹤0.01% | 1027 |
|
|
2020
Q4 | $2K | Sell |
125
-221
| -64% | -$3.54K | ﹤0.01% | 1014 |
|
|
2020
Q3 | $6K | Sell |
346
-1,867
| -84% | -$32.4K | ﹤0.01% | 958 |
|
|
2020
Q2 | $40K | Buy |
2,213
+1,917
| +648% | +$34.7K | ﹤0.01% | 698 |
|
|
2020
Q1 | $4K | Sell |
296
-181
| -38% | -$2.45K | ﹤0.01% | 818 |
|
|
2019
Q4 | $9K | Sell |
477
-1,889
| -80% | -$35.6K | ﹤0.01% | 906 |
|
|
2019
Q3 | $41K | Buy |
2,366
+146
| +7% | +$2.53K | ﹤0.01% | 598 |
|
|
2019
Q2 | $39K | Sell |
2,220
-4,062
| -65% | -$71.4K | ﹤0.01% | 598 |
|
|
2019
Q1 | $128K | Buy |
+6,282
| New | +$128K | ﹤0.01% | 442 |
|